Visceral fat is associated with brain structure independent of human immunodeficiency virus infection status.

Published on Jun 1, 2017in Journal of NeuroVirology2.354
· DOI :10.1007/S13365-016-0507-7
Jordan E. Lake21
Estimated H-index: 21
(UCLA: University of California, Los Angeles),
Mikhail Popov2
Estimated H-index: 2
(University of Pittsburgh)
+ 5 AuthorsJames T. Becker109
Estimated H-index: 109
(University of Pittsburgh)
Sources
Abstract
The combined effects of human immunodeficiency virus (HIV), obesity, and elevated visceral adipose tissue (VAT) on brain structure are unknown. In a cross-sectional analysis of Multicenter AIDS Cohort Study (MACS) participants, we determined associations between HIV serostatus, adiposity, and brain structure. Men (133 HIV+, 84 HIV–) in the MACS Cardiovascular 2 and magnetic resonance imaging (MRI) sub-studies with CT-quantified VAT and whole brain MRI measured within 1 year were assessed. Voxel-based morphometry analyzed brain volumes. Men were stratified by elevated (eVAT, ≥100cm2) or “normal” (nVAT, 25 kg/m2, smaller gray and white matter volumes, and larger cerebrospinal fluid volume than nVAT men. In multivariate analysis, hypertension, higher adiponectin, higher interleukin-6, age, diabetes mellitus, higher body mass index, and eVAT were associated with brain atrophy (p < 0.05, ordered by increasing strength of association), but HIV serostatus and related factors were generally not. No interactions were observed. Greater VAT was associated with smaller bilateral posterior hippocampus and left mesial temporal lobe and temporal stem white matter volume. Traditional risk factors are more strongly associated with brain atrophy than HIV serostatus, with VAT having the strongest association. However, HIV+ MACS men had disproportionately greater VAT, suggesting the risk for central nervous system effects may be amplified in this population.
📖 Papers frequently viewed together
20078.77Neurology
24 Authors (Andrea Antinori, ..., Valerie Wojna)
1,871 Citations
53 Citations
42 Citations
References49
Newest
#1Alexandra Mangili (Merck Serono)H-Index: 17
#2Julian Falutz (MUHC: McGill University Health Centre)H-Index: 22
Last. Brooke Hayward (Merck Serono)H-Index: 7
view all 5 authors...
Background Tesamorelin, a synthetic analog of human growth hormone-releasing factor, decreases visceral adipose tissue (VAT) in human immunodeficiency virus (HIV)-infected patients with lipodystrophy.
4 CitationsSource
#1Fred R. Sattler (SC: University of Southern California)H-Index: 51
#2Jiaxiu He (SC: University of Southern California)H-Index: 9
Last. J. Allen McCutchan (UCSD: University of California, San Diego)H-Index: 64
view all 14 authors...
Objective We tested our hypothesis that abdominal obesity when associated with increased levels of systemic and CNS immuno-inflammatory mediators contributes to neurocognitive impairment (NCI).
55 CitationsSource
#1Anjali Sharma (Yeshiva University)H-Index: 14
#2Shalanda A. Bynum (USU: Uniformed Services University of the Health Sciences)H-Index: 12
Last. Michael Plankey (Georgetown University)H-Index: 26
view all 8 authors...
Objective: Examine changes in, and factors associated with changing body mass index (BMI) in women following highly active antiretroviral therapy (HAART) initiation. Methods: 1177 HIV-infected Women’s Interagency HIV Study participants who contributed 10,754 years of followup following HAART initiation were studied. Changes in median BMI up to 15 years following HAART initiation, and the highest and lowest BMI reached following HAART initiation were summarized by pre-HAART BMI category (<18.5 [u...
14 CitationsSource
Introduction : Morphological and metabolic complications in HIV patients on antiretroviral therapy remain a challenge. While new cases of lipoatrophy (LA) disappear, irreducible central lipohypertrophy (LH) and metabolic complications require highly specialized management. We described a day hospital dedicated to lipodystrophy (LD) and metabolic disorders in HIV patients on treatment in Geneva, Switzerland, with a focus on LH. Materials and Methods : The “Groupe Lipo & Metabolism” is a multidisc...
3 CitationsSource
Late-onset Alzheimer’s disease (AD) is a chronic neurodegenerative disorder and the most common cause of progressive cognitive dysfunction and dementia. Despite considerable progress in elucidating the molecular pathology of this disease, we are not yet close to unraveling its etiopathogenesis. A battery of neurotoxic modifiers may underpin neurocognitive pathology via deleterious heterogeneous pathologic impact in brain regions, including the hippocampus. Three important neurotoxic factors bein...
26 CitationsSource
#1Jason Paruthi (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 2
#2Natasha Gill (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 1
Last. Christos S. Mantzoros (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 139
view all 3 authors...
Abstract The use of highly active antiretroviral therapy (HAART) in the treatment of human immunodeficiency virus has dramatically altered both the landscape of this disease and the prognosis for those affected. With more patients now receiving HAART, adverse effects such as lipodystrophy and metabolic syndrome have emerged. In HIV/HAART-associated lipodystrophy syndrome (HALS), patients demonstrate fat maldistribution with dyslipidemia, insulin resistance, and other metabolic complications. Rec...
34 CitationsSource
#1Simon P. Mooijaart (LUMC: Leiden University Medical Center)H-Index: 35
#2Naveed Sattar (Glas.: University of Glasgow)H-Index: 172
Last. A.J.M. de Craen (LUMC: Leiden University Medical Center)H-Index: 20
view all 9 authors...
Background Inflammation is involved in the pathogenesis of cardiovascular disease and cognitive decline. Interleukin-6 (IL-6) has a role in cardiovascular disease, but the association of IL-6 concentration and the functional IL-6 -174 polymorphism with cognitive decline has not been demonstrated unequivocally. The objective of this study was to investigate the associations between both high concentration of IL-6 and the -174 promoter polymorphism, and increased cognitive decline in old age. Meth...
69 CitationsSource
#1Julieta Díaz-Delfín (University of Barcelona)H-Index: 12
#2Pere Domingo (Autonomous University of Barcelona)H-Index: 65
Last. Francesc Villarroya (University of Barcelona)H-Index: 71
view all 4 authors...
Abstract Maraviroc (MVC) is a drug approved for use as part of HAART in treatment-experienced HIV-1 patients with CCR5-tropic virus. Despite the current concerns on the alterations in adipose tissue that frequently appear in HIV-infected patients under HAART, there is no information available on the effects of MVC on adipose tissue. Here we studied the effects of MVC during and after the differentiation of human adipocytes in culture, and compared the results with the effects of efavirenz (EFV)....
19 CitationsSource
#1Yalcin Hacioglu (Los Angeles Biomedical Research Institute)H-Index: 8
#2Mohit GuptaH-Index: 11
Last. Matthew J. Budoff (UCLA: University of California, Los Angeles)H-Index: 138
view all 10 authors...
The methodology for use of cardiac CT angiography (CTA) in low risk populations is not well defined. In order to present a reference for future studies, we present CTA methodology that is being used in an epidemiology study- the Multicenter AIDS Cohort Study (MACS).The Multicenter AIDS Cohort Study (MACS) is an on-going multicenter prospective, observational cohort study. The MACS Cardiovascular Disease substudy plans to enroll 800 men (n= 575 HIV seropositive and n=225 HIV seronegative) age 40-...
25 CitationsSource
Leptin therapy in human recombinant form has recently been used in HIV-associated lipodystrophy syndrome on experimental basis in some small short-term clinical trials. It has shown its beneficial effects only in hypoleptinemic HIV-infected patients by causing definite improvement in their insulin sensitivity, glucose tolerance, lipid status, and truncal obesity. Leptin prevents lipotoxicity and activates insulin signaling pathways through several postulated mechanisms. Central leptin insufficie...
8 CitationsSource
Cited By11
Newest
#1Brandon J. Lew (UNMC: University of Nebraska Medical Center)H-Index: 5
#2Mikki D. Schantell (Boys Town)H-Index: 2
Last. Tony W. Wilson (UNMC: University of Nebraska Medical Center)H-Index: 30
view all 9 authors...
A growing literature suggests a relationship between HIV-infection and a molecular profile of age acceleration. However, despite the widely known high prevalence of HIV-related brain atrophy and HIV-associated neurocognitive disorder (HAND), epigenetic age acceleration has not been linked to HIV-related changes in structural MRI. We applied morphological MRI methods to study the brain structure of 110 virally suppressed participants with HIV infection and 122 uninfected controls age 22-72. All p...
2 CitationsSource
#1Mikhail Popov (University of Pittsburgh)H-Index: 2
#2Samantha Molsberry (Harvard University)H-Index: 7
Last. James T. Becker (University of Pittsburgh)H-Index: 109
view all 13 authors...
There are distinct trajectories to cognitive impairment among participants in the Multicenter AIDS Cohort Study (MACS). Here we analyzed the relationship between regional brain volumes and the individual trajectories to impairment in a subsample (n = 302) of the cohort. 302 (167 HIV-infected; mean age = 55.7 yrs.; mean education: 16.2 yrs.) of the men enrolled in the MACS MRI study contributed data to this analysis. We used voxel-based morphometry (VBM) to segment the brain images to analyze gra...
7 CitationsSource
#1Andrew J. Levine (UCLA: University of California, Los Angeles)H-Index: 26
#2Virawudh Soontornniyomkij (UCSD: University of California, San Diego)H-Index: 23
Last. David J. Moore (UCSD: University of California, San Diego)H-Index: 45
view all 9 authors...
: HIV-associated neurocognitive disorders (HAND) describe a spectrum of neuropsychological impairment caused by HIV-1 infection. While the sequence of cellular and physiological events that lead to HAND remains obscure, it likely involves chronic neuroinflammation. Host genetic markers that increase the risk for HAND have been reported, but replication of such studies is lacking, possibly due to inconsistent application of a behavioral phenotype across studies. In the current study, we used hist...
Source
#1Samuel S Bailin (VUMC: Vanderbilt University Medical Center)H-Index: 3
#2Curtis L. Gabriel (VUMC: Vanderbilt University Medical Center)H-Index: 7
Last. John R Koethe (VUMC: Vanderbilt University Medical Center)H-Index: 10
view all 4 authors...
PURPOSE OF REVIEW: The proportion of overweight and obese persons with HIV (PWH) has increased since the introduction of antiretroviral therapy (ART). We aim to summarize recent literature on risks of weight gain, discuss adipose tissue changes in HIV and obesity, and synthesize current understanding of how excess adiposity and HIV contribute to metabolic complications. RECENT FINDINGS: Recent studies have implicated contemporary ART regimens, including use of integrase strand transfer inhibitor...
15 CitationsSource
#1Laura M Campbell (UCSD: University of California, San Diego)H-Index: 7
#2Christine Fennema-Notestine (UCSD: University of California, San Diego)H-Index: 56
Last. Robert K. HeatonH-Index: 119
view all 18 authors...
Objective: Frascati international research criteria for HIV-associated neurocognitive disorders (HAND) are controversial; some investigators have argued that Frascati criteria are too liberal, resulting in a high false positive rate. Meyer et al. recommended more conservative revisions to HAND criteria, including exploring other commonly used methodologies for neurocognitive impairment (NCI) in HIV including the global deficit score (GDS). This study compares NCI classifications by Frascati, Mey...
5 CitationsSource
#1Andrew J. Levine (UCLA: University of California, Los Angeles)H-Index: 26
#2Ned Sacktor (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 65
Last. James T. Becker (University of Pittsburgh)H-Index: 109
view all 3 authors...
The virology of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and the human immune response to the virus are under vigorous investigation. There are now several reports describing neurological symptoms in individuals who develop coronavirus disease 2019 (COVID-19), the syndrome associated with SARS-CoV-2 infection. The prevalence, incidence, and clinical course of these symptoms will become clearer in the coming months and years through epidemiological studies. However, the long-t...
6 CitationsSource
#1Jordan E. Lake (University of Texas Health Science Center at Houston)H-Index: 13
#2Paula Debroy (University of Texas Health Science Center at Houston)H-Index: 5
Last. Todd T. Brown (Johns Hopkins University)H-Index: 49
view all 9 authors...
OBJECTIVES:Adipose tissue (AT) density measurement may provide information about AT quality among people living with HIV (PLWH). We assessed AT density and evaluated relationships between AT density and immuno-metabolic biomarker concentrations in men with HIV. DESIGN:Cross-sectional analysis of men enrolled in the Multicenter AIDS Cohort Study. METHODS:Abdominal visceral (VAT) and subcutaneous (SAT) AT density (Hounsfield Units, HU; less negative=more dense) were quantified from CT scans. Multi...
4 CitationsSource
MRI is becoming more frequently used in studies involving measurements of adipose tissue and volume and composition of skeletal muscles. The large amount of data generated by MRI calls for automated analysis methods. This review article presents a summary of automated and semi-automated techniques published between 2013 and 2017. Technical aspects and clinical applications for MRI-based adipose tissue and muscle composition analysis are discussed based on recently published studies. The conclusi...
16 CitationsSource
As successfully treated individuals with Human Immunodeficiency Virus-infected age, cognitive and health challenges of normal aging ensue, burdened by HIV, treatment side effects, and high prevalence comorbidities, notably, Alcohol Use Disorders (AUD) and Hepatitis C virus (HCV) infection. In 2013, people over 55 years old accounted for 26% of the estimated number of people living with HIV (~1.2 million). The aging brain is increasingly vulnerable to endogenous and exogenous insult which, couple...
14 CitationsSource
#1S. Adrian (CU: University of Colorado Boulder)H-Index: 1
#2Ann Scherzinger (CU: University of Colorado Boulder)H-Index: 27
Last. Kristine M. Erlandson (CU: University of Colorado Boulder)H-Index: 27
view all 12 authors...
Background Tesamorelin, a growth hormone-releasing hormone analogue, decreases visceral adipose tissue in people living with HIV, however, the effects on skeletal muscle fat and area are unknown.
1 CitationsSource